 |
|
|
| |
Abacavir Usage Patterns and Hypersensitivity
Reactions (HSR) in the EuroSIDA cohort
|
| |
| |
Reported by Jules Levin
EACS - 16th European AIDS Conference, October 25-27, 2017. Milan
Ashley Roen1, Kamilla Laut2, Annegret Pelchen-Matthews1, Elena Borodulina3, Luis Caldeira4, Amanda Clarke5, Bonaventura Clotet6, Antonella d'ArminioMonforte7, GerdFätkenheuer8, Jose M. GatellArtigas9, Igor Karpov10, AnastasiiaKuznetsova11, Galina Kyselyova12, IwonaMozer-Lisewska13, Fiona Mulcahy14, Leigh Ragone15, Alexandra Scherrer16, VilmaUzdaviniene17, LinosVandekerckhove18, Vani Vannappagari15, Lars Ostergaard19, Amanda Mocroft1on behalf of the EuroSIDAstudy
1 University College London, London, UK; 2 University of Copenhagen, Copenhagen, Denmark; 3 Samara State Medical University, Samara, Russia; 4 Hospital Santa Maria, Lisbon, Portugal; 5 Royal Sussex County Hospital, Brighton, UK; 6 Hospital UniversitariGermans TriasiPujol, Barcelona, Spain; 7 OspedaleSan Paulo, Milan, Italy; 8 University Hospital Cologne, Cologne, Germany; 9 Hospital Clinic, Barcelona, Spain; 10 Belarus StateMedical University, Minsk, Belarus; 11 Kharkov State Medical University, Kharkov, Ukraine; 12 Crimean Republican AIDS centre, Simferopol, Ukraine; 13 Poznan University of Medical Sciences, Poznan, Poland; 14 St. James' Hospital, Dublin, Ireland; 15 ViiVHealthcare, RTP, North Carolina, USA; 16 University Hospital Zürich, Zürich, Switzerland; 17 Vilnius University Hospital SantariskiuKlinikos, Vilnius, Lithuania; 18 University ZiekenhuisGent, Gent, Belgium; 19 Aarhus Universitetshospital, Skejby, Denmark
|
| |
|
|
|
|
|
